| Previous Close | 35.96 |
| Open | 35.90 |
| Bid | 35.88 x 2400 |
| Ask | 35.89 x 2100 |
| Day's Range | 35.78 - 36.03 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 4,330,592 |
| Avg. Volume | 16,874,860 |
| Market Cap | 213.03B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.20 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.61%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
Markit•4 hours agoSee what the IHS Markit Score report has to say about Pfizer Inc.
Pfizer Inc NYSE:PFE
- Financial Times•5 hours ago
[$$] Pfizer tests new way of putting more drugs on trial
Pfizer has backed a new drug development company with the task of shepherding four of its experimental medicines through clinical trials, in an unusual deal designed to prevent promising products from ...
- Bloomberg•5 hours ago
Pfizer Spins Off New Firm for Some Rare Disease Drugs
Pfizer Inc. will spin off four experimental drugs that it had decided to shelve into a new company, called SpringWorks Therapeutics, to give them a better chance to get developed with the backing of outside ...
